anoth fun day biotech stock colleagu brendan conway ha point thank letter three democrat gileadsci gild rais price concern sovaldi
news ha drag entir biotech sector gilead fall 34 7297 today amgen amgn drop 19 12460 celgen celg declin 22 14674 biogen idec biib drop 45 33161 alexion pharmaceut alxn fall 54 16421
amidst nois barclay ying huang team rais price target amgen 130 115 explain whi
wake chang accaha clinic guidelin treatment elev cholesterol prevent cardiovascular event ha heighten uncertainli around size revenu opportun anticholesterol drug target proprotein convertas subtilisinkexin type 9 also known pcsk9 despit anxieti around shift focu clinic guidelin ldlc goal cardiovascular outcom see thi net posit class increas focu use statin max statin dose drive increas intoler insuffici respond statin estim like scenario approv two popul statinexperienc patient along heterozyg famili hypercholesterolemia hefh c yield peak revenu opportun 2020 78 billion antipcsk9 class investor howev might question revenu opportun biotech drug three democrat ask gilead scienc whi ha charg much sovaldi rbc capit market michael yee team think fear overblown explain thi seem like lot polit gestur unlik turn ani real chang bottomlin buyer thi recent weak layman view believ encourag gilead scienc reach price concess especi econom disadvantag patient thi attempt curb regul price pharmaceut share gilead drop 25 far thi year amgen ha gain 93 celgen ha fallen 13 alexion pharmaceut ha climb 24 biogen idec whose hemophilia drug alprolix canadian approv ha advanc 19
